These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 26714710)

  • 21. LEDGINs inhibit late stage HIV-1 replication by modulating integrase multimerization in the virions.
    Desimmie BA; Schrijvers R; Demeulemeester J; Borrenberghs D; Weydert C; Thys W; Vets S; Van Remoortel B; Hofkens J; De Rijck J; Hendrix J; Bannert N; Gijsbers R; Christ F; Debyser Z
    Retrovirology; 2013 May; 10():57. PubMed ID: 23721378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation on the sucrose binding pocket of HIV-1 Integrase by molecular dynamics and synergy experiments.
    Tintori C; Esposito F; Morreale F; Martini R; Tramontano E; Botta M
    Bioorg Med Chem Lett; 2015 Aug; 25(15):3013-6. PubMed ID: 26048795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resistance to HIV-1 integrase inhibitors: A structural perspective.
    Mouscadet JF; Delelis O; Marcelin AG; Tchertanov L
    Drug Resist Updat; 2010; 13(4-5):139-50. PubMed ID: 20570551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization and structural analysis of HIV-1 integrase conservation.
    Ceccherini-Silberstein F; Malet I; D'Arrigo R; Antinori A; Marcelin AG; Perno CF
    AIDS Rev; 2009; 11(1):17-29. PubMed ID: 19290031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Wikstroelide M potently inhibits HIV replication by targeting reverse transcriptase and integrase nuclear translocation.
    Zhang X; Huang SZ; Gu WG; Yang LM; Chen H; Zheng CB; Zhao YX; Wan DC; Zheng YT
    Chin J Nat Med; 2014 Mar; 12(3):186-93. PubMed ID: 24702804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crystal structure of the HIV-1 integrase core domain in complex with sucrose reveals details of an allosteric inhibitory binding site.
    Wielens J; Headey SJ; Jeevarajah D; Rhodes DI; Deadman J; Chalmers DK; Scanlon MJ; Parker MW
    FEBS Lett; 2010 Apr; 584(8):1455-62. PubMed ID: 20227411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The future of integrase inhibitors of HIV-1.
    Malet I; Calvez V; Marcelin AG
    Curr Opin Virol; 2012 Oct; 2(5):580-7. PubMed ID: 22980926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resistance to pyridine-based inhibitor KF116 reveals an unexpected role of integrase in HIV-1 Gag-Pol polyprotein proteolytic processing.
    Hoyte AC; Jamin AV; Koneru PC; Kobe MJ; Larue RC; Fuchs JR; Engelman AN; Kvaratskhelia M
    J Biol Chem; 2017 Dec; 292(48):19814-19825. PubMed ID: 28972144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural Basis for Inhibitor-Induced Aggregation of HIV Integrase.
    Gupta K; Turkki V; Sherrill-Mix S; Hwang Y; Eilers G; Taylor L; McDanal C; Wang P; Temelkoff D; Nolte RT; Velthuisen E; Jeffrey J; Van Duyne GD; Bushman FD
    PLoS Biol; 2016 Dec; 14(12):e1002584. PubMed ID: 27935939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery and Optimization of Novel Pyrazolopyrimidines as Potent and Orally Bioavailable Allosteric HIV-1 Integrase Inhibitors.
    Li G; Meanwell NA; Krystal MR; Langley DR; Naidu BN; Sivaprakasam P; Lewis H; Kish K; Khan JA; Ng A; Trainor GL; Cianci C; Dicker IB; Walker MA; Lin Z; Protack T; Discotto L; Jenkins S; Gerritz SW; Pendri A
    J Med Chem; 2020 Mar; 63(5):2620-2637. PubMed ID: 32081010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The allosteric HIV-1 integrase inhibitor BI-D affects virion maturation but does not influence packaging of a functional RNA genome.
    van Bel N; van der Velden Y; Bonnard D; Le Rouzic E; Das AT; Benarous R; Berkhout B
    PLoS One; 2014; 9(7):e103552. PubMed ID: 25072705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A highly potent and safe pyrrolopyridine-based allosteric HIV-1 integrase inhibitor targeting host LEDGF/p75-integrase interaction site.
    Maehigashi T; Ahn S; Kim UI; Lindenberger J; Oo A; Koneru PC; Mahboubi B; Engelman AN; Kvaratskhelia M; Kim K; Kim B
    PLoS Pathog; 2021 Jul; 17(7):e1009671. PubMed ID: 34293041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multi-Substituted Quinolines as HIV-1 Integrase Allosteric Inhibitors.
    Dinh LP; Sun J; Glenn CD; Patel K; Pigza JA; Donahue MG; Yet L; Kessl JJ
    Viruses; 2022 Jul; 14(7):. PubMed ID: 35891446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The mechanism of H171T resistance reveals the importance of Nδ-protonated His171 for the binding of allosteric inhibitor BI-D to HIV-1 integrase.
    Slaughter A; Jurado KA; Deng N; Feng L; Kessl JJ; Shkriabai N; Larue RC; Fadel HJ; Patel PA; Jena N; Fuchs JR; Poeschla E; Levy RM; Engelman A; Kvaratskhelia M
    Retrovirology; 2014 Nov; 11():100. PubMed ID: 25421939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV-1 Integrase Binds the Viral RNA Genome and Is Essential during Virion Morphogenesis.
    Kessl JJ; Kutluay SB; Townsend D; Rebensburg S; Slaughter A; Larue RC; Shkriabai N; Bakouche N; Fuchs JR; Bieniasz PD; Kvaratskhelia M
    Cell; 2016 Aug; 166(5):1257-1268.e12. PubMed ID: 27565348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kuwanon-L as a New Allosteric HIV-1 Integrase Inhibitor: Molecular Modeling and Biological Evaluation.
    Esposito F; Tintori C; Martini R; Christ F; Debyser Z; Ferrarese R; Cabiddu G; Corona A; Ceresola ER; Calcaterra A; Iovine V; Botta B; Clementi M; Canducci F; Botta M; Tramontano E
    Chembiochem; 2015 Nov; 16(17):2507-12. PubMed ID: 26360521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crystal structures of novel allosteric peptide inhibitors of HIV integrase identify new interactions at the LEDGF binding site.
    Rhodes DI; Peat TS; Vandegraaff N; Jeevarajah D; Newman J; Martyn J; Coates JA; Ede NJ; Rea P; Deadman JJ
    Chembiochem; 2011 Oct; 12(15):2311-5. PubMed ID: 21850718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 1,4-Bis(5-(naphthalen-1-yl)thiophen-2-yl)naphthalene, a small molecule, functions as a novel anti-HIV-1 inhibitor targeting the interaction between integrase and cellular Lens epithelium-derived growth factor.
    Gu WG; Ip DT; Liu SJ; Chan JH; Wang Y; Zhang X; Zheng YT; Wan DC
    Chem Biol Interact; 2014 Apr; 213():21-7. PubMed ID: 24480521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, Synthesis, and Preclinical Profiling of GSK3739936 (BMS-986180), an Allosteric Inhibitor of HIV-1 Integrase with Broad-Spectrum Activity toward 124/125 Polymorphs.
    Naidu BN; Patel M; McAuliffe B; Ding B; Cianci C; Simmermacher J; Jenkins S; Parker DD; Sivaprakasam P; Khan JA; Kish K; Lewis H; Hanumegowda U; Krystal M; Meanwell NA; Kadow JF
    J Med Chem; 2022 Mar; 65(6):4949-4971. PubMed ID: 35235334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV-1 Integrase-Targeted Short Peptides Derived from a Viral Protein R Sequence.
    Zhao XZ; Métifiot M; Kiselev E; Kessl JJ; Maddali K; Marchand C; Kvaratskhelia M; Pommier Y; Burke TR
    Molecules; 2018 Jul; 23(8):. PubMed ID: 30049955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.